首页> 外文期刊>Biosensors & Bioelectronics: The International Journal for the Professional Involved with Research, Technology and Applications of Biosensers and Related Devices >G-quadruplex DNAzyme-based electrochemiluminescence biosensing strategy for VEGF(165) detection: Combination of aptamer-target recognition and T7 exonuclease-assisted cycling signal amplification
【24h】

G-quadruplex DNAzyme-based electrochemiluminescence biosensing strategy for VEGF(165) detection: Combination of aptamer-target recognition and T7 exonuclease-assisted cycling signal amplification

机译:基于G四联体DNA酶的电化学发光生物传感策略用于VEGF(165)检测:适体靶标识别和T7核酸外切酶辅助循环信号放大的组合

获取原文
获取原文并翻译 | 示例
           

摘要

The expression profile of vascular endothelial growth factor (VEGF) is highly correlated with the occurrence and development of cancer. This work reports an electrochemiluminescence (ECL) approach for highly sensitive detection of VEGF(165). This approach comprises aptamer-target recognition, T7 exonuclease (17 Exo)-assisted cycling signal amplification and efficient quenching of ECL of CdS:Eu nanocrystals (NCs) by using DNAzyme. In this assay, CdS:Eu NCs were used as the ECL substrate, A guanine (G)-rich single-stranded DNA (ssDNA) sequence and VEGF(165) aptamer were co-immobilized on the surface of the CdS:Eu NCs modified glassy carbon electrode. After recognition and binding to VEGF(165), the aptamer moved away from the electrode surface and induced the proposed cyclic cleavage of the target DNA with T7 Exo. A large amount of G-rich ssDNA was released on the CdS:Eu film and folded into G-quadruplex/hemin DNAzyme in the presence of hemin and K+, consequently decreasing the ECL intensity of CdS:Eu. A good linearity was obtained for VEGF(165) detection within the range of 1 pM to 20 nM with a detection limit of 0.2 pM. This assay could be a universal and promising protocol for detection of various biomarkers for early clinical diagnosis. (C) 2015 Elsevier B.V. All rights reserved.
机译:血管内皮生长因子(VEGF)的表达谱与癌症的发生和发展高度相关。这项工作报告了电化学发光(ECL)方法用于VEGF的高灵敏度检测(165)。此方法包括使用DNAzyme进行适体靶标识别,T7核酸外切酶(17 Exo)辅助的循环信号扩增以及CdS:Eu纳米晶体(NCs)的ECL的有效猝灭。在该测定中,将CdS:Eu NCs用作ECL底物,将富含鸟嘌呤(G)的单链DNA(ssDNA)序列和VEGF(165)适体共固定在修饰的CdS:Eu NCs的表面上玻碳电极。识别并与VEGF(165)结合后,适体从电极表面移开,并诱导了T7 Exo对靶DNA的环状裂解。大量富含G的ssDNA在CdS:Eu膜上释放,并在存在hemin和K +的情况下折叠成G-四链体/ hemin DNAzyme,因此降低了CdS:Eu的ECL强度。 VEGF(165)检测在1 pM至20 nM的范围内具有良好的线性,检测限为0.2 pM。该测定法可能是用于检测各种生物标志物以进行早期临床诊断的通用且有希望的方案。 (C)2015 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号